Chiesi Group Company Profile

13:52 EDT 31st October 2014 | BioPortfolio

The Company, founded in Parma in 1935, is today an international reality in the pharmaceutical market. With global operations consisting of 21 direct affiliates, 3 manufacturing sites, and 3 research centres, the Group has over 2,700 employees, of whom 300 are involved in research and development activities.

Chiesi’s technologies and products are available in over 50 countries through a strategic alliances network of international pharmaceutical groups developed both on a global and local scale. Group turnover reached 565 million Euros in 2005. Historically, the continuous development of the Company has been based on strategic planning for innovation, internationalisation, socially compatible economical values, and use of effective organizational structures.

Chiesi's formula for success is based on a peculiar approach that allows to combine factors often thought of as opposites in the pharmaceutical industry – such as research and ethics, technology and humanity, commitment to results and concern for individuals, reliability and empathy – while encouraging innovation at all levels. The final goal is the creation of value through innovation.

Location

Chiesi Farmaceutici S.p.A.Via Palermo, 26/A,
Parma
43100
Italy

Contact

Phone: 39 0521 2791
Fax: 39 0521 774468
Email: info@chiesigroup.com


News Articles [431 Associated News Articles listed on BioPortfolio]

Chiesi, Pappas launch rare disease-focused VC firm

Chiesi Farmaceutici S.p.A. (Parma, Italy) and A. M. Pappas & Associates launched a new VC firm, Chiesi Ventures, to invest in early stage research on rare and orphan diseases. A. M. Pappas is an inves...

Pappas, Chiesi Venture Fund Joins Ranks of Pharma & VC Partnerships

Art Pappas has overseen his own firm’s venture capital investments for 20 years. Now the veteran life sciences investor is adding on a new role, scoping out investment opportunities for a pharmaceut...

Chiesi expands rare disease universe

Ebb & Flow Chiesi expands rare disease universe Chiesi Farmaceutici S.p.A. launched a strategic venture fund focused on rare and Orphan diseases - where the Italian pharma has been busily expanding - ...

Chiesi links with UCL to test a novel therapeutic for birth asphyxia

Privately-held Italian drugmaker Chiesi Farmaceutici has entered into a collaboration with University College London to test a novel melatonin formulation as a brain protective medicine for babies who...

Chiesi Launches Venture Capital Fund via Strategic Collaboration with A. M. Pappas & Associates

PARMA, Italy and RESEARCH TRIANGLE PARK, North Carolina, September 2, 2014 /PRNewswire/ -- The Chiesi Group announced today the launch of its venture capital fund, Chiesi Ventures, via a strategic c...

Chiesi and uniQure delay Glybera launch to add data

Netherlands-based venture capital backed human gene therapy firm uniQure and privately-held Italian drugmaker Chiesi Farmaceutici have provided an update on preparations relating to the launch of Glyb...

Veloxis and Chiesi receive approval from European Commission on anti-organ rejection drug

Denmark-based Veloxis Pharmaceuticals and Italian company Chiesi Farmaceutici have said that the European Commission has granted marketing authorization for their drug Envarsus (formerly LCP-Tacro), w...

Chiesi USA, Inc. (CRTX) - Strategic SWOT Analysis Review

Recently added to the BioPortfolio report store, Chiesi USA, Inc. (CRTX) - Strategic SWOT Analysis Review is a new report from GlobalData published on 2014-07-14. This 28-page report is available in ...

PubMed Articles [2384 Associated PubMed Articles listed on BioPortfolio]

The Ontogeny of the Motivation That Underlies In-Group Bias.

Humans demonstrate a clear bias toward members of their own group over members of other groups in a variety of ways. It has been argued that the motivation underlying this in-group bias in adults may ...

Study About the Effects of Different Fitness Sports on Cognitive Function and Emotion of the Aged.

The aim of the study was to explore the effects of different fitness sports on cognitive function and emotion of the aged people. A total of 150 subjects aged between 60 and 70 were recruited from She...

The Attenuation of Lung Ischemia Reperfusion Injury by Oxymatrine.

To investigate the protective effects of oxymatrine (OMT) on lung ischemia reperfusion injury (LIRI) in rabbits, models of LIRI in rabbit were used. Thirty-two rabbits were randomly divided into four ...

The effect of preemptive perianal ropivacaine and ropivacaine with dexmedetomidine on pain after hemorrhoidectomy: a prospective, randomized, double-blind, placebo-controlled study.

The objective of this study was to assess the efficacy of perianal infiltration of ropivacaine and dexmedetomidine added to ropivacainein in the relief of pain after hemorrhoidectomy. Patients in grou...

The Effects of Within- and Between-Group Competition on Trust and Trustworthiness among Acquaintances.

Several studies have indicated that between-group competition is a key stimulator of trust and trustworthiness. Another important but neglected type of competition may also affect trust and trustworth...

Clinical Trials [1369 Associated Clinical Trials listed on BioPortfolio]

Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma

The purpose of this trial is to verify if the test treatment BDP 250 mcg/salbutamol 100 mcg HFA pMDI fixed combination is non-inferior to BDP 250 mcg/salbutamol 100 mcg pMDI fixed combina...

Does Cognitive Rehabilitation Demonstrate Benefits in the Group Setting With People Whom Have Experienced Brain Injury?

The purpose of this study is to determine whether there is benefit from providing cognitive rehabilitation in the group setting. Several standardized tools will be used to measure progres...

Short Term Group Therapy for OCD

Assessing OCD before and after group therapy

Psychological Prevention of Internalizing Disorders

The purpose of this study is to determine whether cognitive-behavioral group prevention (CBT-G) for german children is effective and to what extent parental group training moderates outcom...

Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -

The purpose of the study is to verify superiority of the lafutidine group over the placebo group and non-inferiority to the famotidine group in terms of endoscopic healing rate of the pati...

Companies [1424 Associated Companies listed on BioPortfolio]

Chiesi Group

The Company, founded in Parma in 1935, is today an international reality in the pharmaceutical market. With global operations consisting of 21 direct affiliates, 3 manufacturing sites, and 3 research ...

Chiesi Farmaceutici S.p.A.

Chiesi Pharmaceuticals, which started up in 1935 as a small family company is today an international company in the pharmaceutical sector and operates in all 5 continents with 24 direct branches, 3 ...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

ACE Group

Celebrating 25 years of insuring progress, the ACE Group is a global leader in insurance and reinsurance serving a diverse group of clients. Headed by ACE Limited (NYSE:ACE), a co...

More Information about "Chiesi Group" on BioPortfolio

We have published hundreds of Chiesi Group news stories on BioPortfolio along with dozens of Chiesi Group Clinical Trials and PubMed Articles about Chiesi Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chiesi Group Companies in our database. You can also find out about relevant Chiesi Group Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record